Literature DB >> 21298374

Exploring the differential diagnosis of joint complaints in pediatric patients with inflammatory bowel disease.

Jennifer Dotson1, Wallace Crandall, Sharon Bout-Tabaku.   

Abstract

About one quarter of children with inflammatory bowel disease (IBD) experience an extraintestinal manifestation, with the most common being arthritis or arthralgia. Because of the frequency of these joint complaints and their effect on quality of life, it is important to consider all possible etiologies in order to promptly evaluate, diagnose, and possibly refer to other specialists. Pediatric gastroenterologist and IBD specialists are cognizant of the extraintestinal joint manifestations, but may be less familiar with rheumatic disease and the musculoskeletal examination. We explore the differential diagnosis of joint complaints in children, with a focus on IBD-related disease and rheumatic disease. © Springer Science+Business Media, LLC 2011

Entities:  

Mesh:

Year:  2011        PMID: 21298374     DOI: 10.1007/s11894-011-0181-0

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  26 in total

1.  Comparison of antinuclear antibody testing methods by ROC analysis with reference to disease diagnosis.

Authors:  R A Gniewek; C Sandbulte; P C Fox
Journal:  Clin Chem       Date:  1997-10       Impact factor: 8.327

2.  The incidence of joint involvement with adjacent osteomyelitis in pediatric patients.

Authors:  M H Perlman; M J Patzakis; P J Kumar; P Holtom
Journal:  J Pediatr Orthop       Date:  2000 Jan-Feb       Impact factor: 2.324

3.  Musculoskeletal screening examination (pGALS) for school-age children based on the adult GALS screen.

Authors:  H E Foster; L J Kay; M Friswell; D Coady; A Myers
Journal:  Arthritis Rheum       Date:  2006-10-15

Review 4.  The joint-gut axis in inflammatory bowel diseases.

Authors:  Lianne K P M Brakenhoff; Désirée M van der Heijde; Daniel W Hommes; Tom W J Huizinga; Herma H Fidder
Journal:  J Crohns Colitis       Date:  2009-11-30       Impact factor: 9.071

5.  Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis.

Authors:  E Jaakkola; I Herzberg; K Laiho; M C N M Barnardo; J J Pointon; M Kauppi; K Kaarela; E Tuomilehto-Wolf; J Tuomilehto; B P Wordsworth; M A Brown
Journal:  Ann Rheum Dis       Date:  2005-10-25       Impact factor: 19.103

6.  Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

Authors:  Stephen B Hanauer; Brian G Feagan; Gary R Lichtenstein; Lloyd F Mayer; S Schreiber; Jean Frederic Colombel; Daniel Rachmilewitz; Douglas C Wolf; Allan Olson; Weihang Bao; Paul Rutgeerts
Journal:  Lancet       Date:  2002-05-04       Impact factor: 79.321

7.  Infliximab retreatment in adults and children with Crohn's disease: risk factors for the development of delayed severe systemic reaction.

Authors:  Subra Kugathasan; Michael B Levy; Kia Saeian; Sotirios Vasilopoulos; Joseph P Kim; Devang Prajapati; Jeanne Emmons; Alfonso Martinez; Kevin J Kelly; David G Binion
Journal:  Am J Gastroenterol       Date:  2002-06       Impact factor: 10.864

Review 8.  Joint involvement associated with inflammatory bowel disease.

Authors:  M De Vos
Journal:  Dig Dis       Date:  2009-11-04       Impact factor: 2.404

9.  Arthritis associated with inflammatory bowel disease in children. Relationship of joint disease to activity and severity of bowel lesion.

Authors:  M H Passo; J F Fitzgerald; K D Brandt
Journal:  Dig Dis Sci       Date:  1986-05       Impact factor: 3.199

10.  The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients.

Authors:  Jean-Frederic Colombel; Edward V Loftus; William J Tremaine; Laurence J Egan; W Scott Harmsen; Cathy D Schleck; Alan R Zinsmeister; William J Sandborn
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

View more
  2 in total

Review 1.  Diagnosis and treatment of low back pain in the pediatric population.

Authors:  Alysha J Taxter; Nancy A Chauvin; Pamela F Weiss
Journal:  Phys Sportsmed       Date:  2014-02       Impact factor: 2.241

2.  Enthesitis is an Extraintestinal Manifestation of Pediatric Inflammatory Bowel Disease.

Authors:  Daniel B Horton; David D Sherry; Robert N Baldassano; Pamela F Weiss
Journal:  Ann Paediatr Rheumatol       Date:  2012-01-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.